Evidence is accumulating on the interaction between tuberculosis (TB) and COVID-19. The
aim of the present review is to report the available evidence on the interaction between …

Rapid diagnosis is one key pillar to end tuberculosis (TB). Point-of-care tests (POCTs)
facilitate early detection, immediate treatment, and reduced transmission of TB disease. This …

Tuberculosis (TB) is an infectious disease that threatens> 10 million people annually.
Despite advances in TB diagnostics, patients continue to receive an insufficient diagnosis as …

Microemulsions (MEs) are ideal for obtaining high‐quality inorganic nanoparticles. As
thermodynamically stable systems with a nanometer‐sized droplet phase that serves as a …

Background: There is an urgent need for more accurate screening tests for tuberculosis (TB).
We assessed the diagnostic accuracy of C-reactive protein (CRP) as a screening test for …

Background Less than one-third of patients who are estimated to be infected with multidrug-
resistant tuberculosis (MDR-TB) receive MDR-TB treatment regimens, and only 48% of …

BACKGROUND: There are currently large gaps in unit cost data for TB, and substantial
variation in the quality and methods of unit cost estimates. Uncertainties remain about …

Introduction Over the years, technological and process innovations enabled active case
finding (ACF) programs to expand their capacities and scope to have evolved to close gaps …

Isoniazid‐filled Fe2O3 hollow nanospheres (INH@ Fe2O3, diameter< 30 nm, 48 wt% INH‐
load) are prepared for the first time and suggested for tuberculosis therapy. After dextran …

BACKGROUND: Despite a scarcity of tuberculosis (TB) cost data, a substantial body of
evidence has been accumulating for drug-susceptible TB (DS-TB) treatment. In this study …